Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2749118 | 0.86 | MAOA (0.59) | MAOAMAOB | |
| SCHEMBL21044999 | 0.83 | AKR1B1 (0.34) | MAOAMAOB | |
| SCHEMBL8114347 | 0.80 | ABCC4 (0.39) | MAOAMAOB | |
| SCHEMBL7765422 | 0.72 | MAOA (0.35) | MAOAMAOBCYP3A4TSHR | |
| SCHEMBL1486046 | 0.71 | — | — | |
| SCHEMBL27459297 | 0.71 | CYP1A2 (0.40) | MAOAMAOB | |
| SCHEMBL8114343 | 0.71 | — | — | |
| SCHEMBL19691108 | 0.70 | AHR (0.36) | — | |
| SCHEMBL744528 | 0.69 | LMNA (0.35) | — | |
| SCHEMBL1713375 | 0.68 | ALOX5 (0.42) | MAOACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090326188-A1 | Method for producing polyarylene | SUMITOMO CHEMICAL COMPANY, LIMITED | 2009-12-31 | — | — | US | claimed |
| EP-2065420-A1 | METHOD FOR PRODUCING POLYARYLENE | Sumitomo Chemical Company, Limited (JP) | 2009-06-03 | — | — | EP | claimed |
| CN-117616032-A | Rare earth complex | 东曹株式会社 | 2024-02-27 | — | — | CN | disclosed |
| WO-2024024824-A1 | MODIFIED SULFIDE SOLID ELECTROLYTE, PRODUCTION METHOD FOR SAME, ELECTRODE MIXTURE, AND LITHIUM-ION BATTERY | 出光興産株式会社 | 2024-02-01 | — | — | WO | disclosed |
| WO-2024024825-A1 | MODIFIED SULFIDE SOLID ELECTROLYTE AND PRODUCTION METHOD THEREFOR, AND ELECTRODE COMPOSITE MATERIAL AND LITHIUM ION BATTERY | 出光興産株式会社 | 2024-02-01 | — | — | WO | disclosed |
| WO-2023282236-A1 | RARE EARTH COMPLEX | 東ソー株式会社 | 2023-01-12 | — | — | WO | disclosed |
| US-10815258-B2 | Phosphine oxides reduction | RHODIA OPERATIONS (FR) | 2020-10-27 | — | — | US | disclosed |
| US-20200231613-A1 | PHOSPHINE OXIDES REDUCTION | SPECIALTY OPERATIONS FRANCE (FR) | 2020-07-23 | — | — | US | disclosed |
| CN-109963848-A | Novel substituted N- (3-fluoropropyl) -pyrrolidine compounds, process for their preparation and their therapeutic use | 赛诺菲 | 2019-07-02 | — | — | CN | disclosed |
| WO-2017041250-A1 | PHOSPHINE OXIDES REDUCTION | RHODIA OPERATIONS (FR) | 2017-03-16 | — | — | WO | disclosed |
| EP-2552928-B1 | A PROCESS FOR THE REDUCTION OF A TERTIARY PHOSPHINE OXIDE TO THE CORRESPONDING TERTIARY PHOSPHINE IN THE PRESENCE OF A CATALYST AND USE OF A TERTIARY PHOSPHINE FOR REDUCING A TERTIARY PHOSPHINE OXIDE IN THE PRESENCE OF A CATALYST. | CHROMAFORA AB (SE) | 2015-04-15 | — | — | EP | disclosed |
| US-8436181-B2 | Production process of optically active 3-quinuclidinol derivative | NIPPON SODA CO., LTD. (JP) | 2013-05-07 | — | — | US | disclosed |
| US-8426647-B2 | — | — | 2013-04-23 | — | — | US | disclosed |
| EP-2552928-A1 | A PROCESS FOR THE REDUCTION OF A TERTIARY PHOSPHINE OXIDE TO THE CORRESPONDING TERTIARY PHOSPHINE IN THE PRESENCE OF A CATALYST AND USE OF A TERTIARY PHOSPHINE FOR REDUCING A TERTIARY PHOSPHINE OXIDE IN THE PRESENCE OF A CATALYST | Chromafora AB (SE) | 2013-02-06 | — | — | EP | disclosed |
| US-20130012725-A1 | PROCESS FOR THE REDUCTION OF A TERTIARY PHOSPHINE OXIDE TO THE CORRESPONDING TERTIARY PHOSPHINE IN THE PRESENCE OF A CATALYST AND USE OF A TERTIARY PHOSPHINE FOR REDUCING A TERTIARY PHOSPHINE OXIDE IN THE PRESENCE OF A CATALYST | CHROMAFORA AB (SE) | 2013-01-10 | — | — | US | disclosed |
| WO-2011123037-A1 | A PROCESS FOR THE REDUCTION OF A TERTIARY PHOSPHINE OXIDE TO THE CORRESPONDING TERTIARY PHOSPHINE IN THE PRESENCE OF A CATALYST AND USE OF A TERTIARY PHOSPHINE FOR REDUCING A TERTIARY PHOSPHINE OXIDE IN THE PRESENCE OF A CATALYST | CHROMAFORA AB (SE) | 2011-10-06 | — | — | WO | disclosed |
| US-20100174081-A1 | PRODUCTION PROCESS OF OPTICALLY ACTIVE 3-QUINUCLIDINOL DERIVATIVE | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2010-07-08 | — | — | US | disclosed |
| EP-2186812-A1 | PRODUCTION PROCESS OF OPTICALLY ACTIVE 3-QUINUCLIDINOL DERIVATIVE | National University Corporation Hokkaido University (JP) | 2010-05-19 | — | — | EP | disclosed |
| US-20090326188-A1 | Method for producing polyarylene | SUMITOMO CHEMICAL COMPANY, LIMITED | 2009-12-31 | — | — | US | disclosed |
| EP-2065420-A1 | METHOD FOR PRODUCING POLYARYLENE | Sumitomo Chemical Company, Limited (JP) | 2009-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10815258-B2 | Phosphine oxides reduction | PHOSPHO1, PSPH, PTEN | MAOA 2898/4885MAOB 2441/4885CYP3A4 2013/4885 |
| US-20100174081-A1 | PRODUCTION PROCESS OF OPTICALLY ACTIVE 3-QUINUCLIDINOL DERIVATIVE | GRK7, NR2E3, GRK1 | MAOA 1966/4885MAOB 1910/4885CYP3A4 1711/4885 |
| US-20130012725-A1 | PROCESS FOR THE REDUCTION OF A TERTIARY PHOSPHINE OXIDE TO THE CORRESPONDING TERTIARY PHOSPHINE IN THE PRESENCE OF A CATALYST AND USE OF A TERTIARY PHOSPHINE FOR REDUCING A TERTIARY PHOSPHINE OXIDE IN THE PRESENCE OF A CATALYST | PSPH, PNPO, PHOSPHO1 | MAOA 776/4885MAOB 667/4885CYP3A4 1008/4885 |
| US-20200231613-A1 | PHOSPHINE OXIDES REDUCTION | PHOSPHO1, PSPH, PTEN | MAOA 2898/4885MAOB 2441/4885CYP3A4 2013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.